The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer.
Anticancer Res
; 36(11): 5781-5792, 2016 11.
Article
in En
| MEDLINE
| ID: mdl-27793900
Key words
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Toll-Like Receptor 4
Limits:
Animals
Language:
En
Journal:
Anticancer Res
Year:
2016
Document type:
Article